Neurotron, Inc

Neurotron, Incorporated is a US-based medical device manufacturer established in 1981, headquartered in Aurora, Colorado. The company specializes in the Neurometer® CPT® (Current Perception Threshold), a proprietary neurodiagnostic device for painless, non-invasive sensory nerve fiber testing. The Neurometer® CPT® evaluates small unmyelinated C-fibers, small myelinated Aδ-fibers, and large myelinated Aβ-fibers at any cutaneous site, detecting >90% of sensory nerve fiber types using a standardized, double-blind automated test procedure. FDA-cleared since 1986, the device has been used in over one million tests globally and is supported by more than 800 peer-reviewed publications. The technology quantifies both hyperesthesia and hypoesthesia, monitors nerve regeneration progression, and enables early detection of nerve damage from diabetes, carpal tunnel syndrome, spinal injury, sciatica, radiculopathy, and polyneuropathy. Unlike traditional electrodiagnostic and biopsy procedures, CPT® measurements are unaffected by skin temperature, edema, or electromagnetic interference. The device is portable, battery-powered, painless, non-invasive, and requires no special environmental shielding. Neuval® CPT® software evaluates results against established norms, manages patient records, and generates clinical reports. The company markets through direct sales and an international distributor network across China, Japan, Switzerland, Korea, Benelux, UAE, and Kuwait. Products are manufactured in the USA.